Lion TCR Announces FDA IND Clearance for its LioCyx-M004 for Hepatocellular Carcinoma
Lion TCR Pte Ltd, a clinical-stage biotech company specialized in T Cell Receptor (TCR) T cell therapy today announced that...
Lion TCR Pte Ltd, a clinical-stage biotech company specialized in T Cell Receptor (TCR) T cell therapy today announced that...